Interrogating the Safety & Efficacy Profile of JAK1 Selective Inhibitors in Inflammatory Disorders to Apply Learnings to the Skin

Time: 11:30 am
day: Pre-Conference Workshop Day


  • What can we learn from advances of JAK inhibitors in alternative indications?
  • Investigating mechanistic data and early clinical trial biomarker data to assess efficacy and safety of JAK1 inhibitors
  • Navigating clinical decision making and illuminating opportunities for indication expansion in inflammatory disorders